Cognitive impairment in systemic lupus erythematosus women with elevated autoantibodies and normal single photon emission computerized tomography

Psychotherapy and Psychosomatics

Volumn 81, Issue 5, 2012, Pages 276-285

  Peretti, Charles Siegfried ^a,g   Peretti, Charles Roger ^b   Kozora, Elizabeth ^d   Papathanassiou, Dimitri ^c   Chouinard, Virginie Anne ^e   Chouinard, Guy ^f  

^a HÔPITAL SAINT ANTOINE   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSTITUT JEAN GODINOT   (France)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^g XIII Congress of the European Society for Dermatology and Psychiatry   (Italy)

Author keywords

Caucasian SLE women; Cognitive dysfunction in SLE; Cognitive impairment in SLE; Neuropsychiatric SLE; Non neuropsychiatric SLE; SLE autoantibodies; SPECT in SLE; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; CYSTEINE ETHYL ESTER TC 99M; DOUBLE STRANDED DNA ANTIBODY; PREDNISONE;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; AUDITORY MEMORY; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FRANCE; HUMAN; IMMUNOFLUORESCENCE TEST; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROOP TEST; SYSTEMIC LUPUS ERYTHEMATOSUS; TASK PERFORMANCE; TRAIL MAKING TEST A AND B; VISUAL MEMORY; WAIS DIGIT SYMBOL SUBSTITUTION TEST; WECHSLER INTELLIGENCE SCALE; WORKING MEMORY;

ADULT; AUTOANTIBODIES; BRAIN; CASE-CONTROL STUDIES; COGNITION; COGNITION DISORDERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; REGIONAL BLOOD FLOW; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84864099372     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000336555     Document Type: Article

References (47)

1. Rahman A, Isenberg DA: Systemic lupus erythematosus. N Engl J Med 2008; 358: 929-939.
2. Denburg SD, Denburg JA: Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus. Lupus 2003; 12: 883-890.
3. Deberdt R, van Hooren J, Amery W: Antinuclear factor, a dysimmunological feature in mental depression. A preliminary communication. Psychother Psychosom 1974; 24: 119-122.
4. Marra D, Amoura Z, Soussan N, Haroche J, Consoli A, Ghillami-Dalbin P, Diemert MC, Musset L, Piette JC, Cohen D: Plasma exchange in patients with stuporous catatonia and systemic lupus erythematosus. Psychother Psychosom 2008; 77: 195-196.
5. Stern M, Robbins ES: Psychoses in systemic lupus erythematosus. Arch Gen Psychiatry 1960; 3: 205-212.
6. Guze SB: The occurrence of psychiatric illness in systemic lupus erythematosus. Am J Psychiatry 1967; 123: 1562-1570.
7. Wright MT: Neuropsychiatric illness in systemic lupus erythematosus: insights from a patient with erotomania and Geschwind's syndrome. Am J Psychiatry 2010; 167: 502-507.
8. Sundquist K, Li X, Hemminki K, Sundquist J: Subsequent risk of hospitalization for neuropsychiatric disorders in patients with rheumatic diseases: a nationwide study from Sweden. Arch Gen Psychiatry 2008; 65: 501-507.
9. Appenzeller S, Cendes F, Costallat LT: Acute psychosis in systemic lupus erythematosus. Rheumatol Int 2008; 28: 237-243.
10. Kozora E, Ellison MC, Waxmonsky JA, Wamboldt FS, Patterson TL: Major life stress, coping styles, and social support in relation to psychological distress in patients with systemic lupus erythematosus. Lupus 2005; 14: 363-372.
11. Kozora E, Brown M, Filley C, Zhang L, Miller D, West S, Pelzman J, Arciniegas D: Memory impairment associated with neurometabolic abnormalities of the hippocampus in patients with non-neuropsychiatric systemic lupus erythematosus. Lupus 2011; 20: 598-606.
12. Navarrete-Navarrete N, Peralta-Ramirez MI, Sabio-Sanchez JM, Coin MA, Robles-Ortega H, Hidalgo-Tenorio C, Ortego-Centeno N, Callejas-Rubio JL, Jimenez-Alonso J: Efficacy of cognitive behavioural therapy for the treatment of chronic stress in patients with lupus erythematosus: a randomized controlled trial. Psychother Psychosom 2010; 79: 107-115.
13. Pawlak CR, Witte T, Heiken H, Hundt M, Schubert J, Wiese B, Bischoff-Renken A, Gerber K, Licht B, Goebel MU, Heijnen CJ, Schmidt RE, Schedlowski M: Flares in patients with systemic lupus erythematosus are associated with daily psychological stress. Psychother Psychosom 2003; 72: 159-165.
14. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
15. Kozora E: Neuropsychological functioning in systemic lupus erythematosus; in Morgan JE, Ricker JH (eds): Textbook of Clinical Neuropsychology. New York, Taylor & Francis, 2008, pp 636-659.
16. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB: Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526-1533.
17. Kowal C, Degiorgio LA, Lee JY, Edgar MA, Huerta PT, Volpe BT, Diamond B: Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci USA 2006; 103: 19854-19859.
18. Omdal R, Brokstad K, Waterloo K, Koldingsnes W, Jonsson R, Mellgren SI: Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors. Eur J Neurol 2005; 12: 392-398.
19. Kao CH, Lan JL, ChangLai SP, Liao KK, Yen RF, Chieng PU: The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus. Eur J Nucl Med 1999; 26: 129-134.
20. Huang WS, Chiu PY, Tsai CH, Kao A, Lee CC: Objective evidence of abnormal regional cerebral blood flow in patients with systemic lupus erythematosus on 99m TC-ECD brain SPECT. Rheumatol Int 2002; 22: 178-181.
21. Lin WY, Wang SJ, Yen TC, Lan JL: Technetium-99m-HMPAO brain SPECT in systemic lupus erythematosus with CNS involvement. J Nucl Med 1997; 38: 1112-1115.
22. Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S, Lee AT, Chung SA, Ferreira RC, Pant PV, Ballinger DG, Kosoy R, Demirci FY, Kamboh MI, Kao AH, Tian C, Gunnarsson I, Bengtsson AA, Rantapaa-Dahlqvist S, Petri M, Manzi S, Seldin MF, Ronnblom L, Syvanen AC, Criswell LA, Gregersen PK, Behrens TW: Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX . N Engl J Med 2008; 358: 900-909.
23. Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
24. Sheehan DV, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The mini-international neuropsychiatric interview: the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: 34-57.
25. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
26. Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, Neri R, Bombardieri S: Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992; 10: 541-547.
27. Wechsler D: Wechsler Adults Intelligence Scale WAIS-III. Paris, Editions du Centre de Psychologie Appliquée, 2000.
28. Grober E, Buschke H: Genuine memory deficits in dementia. Dev Neuropsychol 1987; 3: 13-36.
29. Shum DH, McFarland K, Bain JD, Humphreys MS: Construct validity of eight tests of attention: comparison of normal and closed head injured samples. Clin Neuropsychol 1990; 4: 151-162.
30. Reitan R, Wolfson D: The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Tucson, Neuropsychology Press, 1985.
31. Zazzo R (ed): Test des deux barrages. Actualités pédagogiques et psychologiques. Paris, Delachaux & Niestle, 1974, vol 7.
32. Lezak MD (ed): Neuropsychological Assessment. New York, Oxford University Press, 1983.
33. Stroop JR: Studies of interference in serial verbal reactions. J Exp Psychol Gen 1935; 18: 643-661.
34. Tombaugh TN: Trail Making Test A and B: normative data stratified by age and education. Arch Clin Neuropsychol 2004; 19: 203-214.
35. Van der Elst W, van Boxtel MP, van Breukelen GJ, Jolles J: The letter digit substitution test: normative data for 1,858 healthy participants aged 24-81 from the Maastricht Aging Study (MAAS): influence of age, education, and sex. J Clin Exp Neuropsychol 2006; 28: 998-1009.
36. Fossati P, Coyette F, Ergis A: Influence of age and executive functioning on verbal memory of inpatients with depression. J Affect Disord 2002; 68: 261-271.
37. Chelune GJ, Baer RA: Developmental norms for the Wisconsin Card Sorting Test. J Clin Exp Neuropsychol 1986; 8: 219-228.
38. Hetem LA, Danion JM, Diemunsch P, Brandt C: Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers. Psychopharmacology (Berl) 2000; 152: 283-288.
39. Kao CH, Ho YJ, Lan JL, Changlai SP, Liao KK, Chieng PU: Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings. Arthritis Rheum 1999; 42: 61-68.
40. Appenzeller S, Cendes F, Costallat LT: Cognitive impairment and employment status in systemic lupus erythematosus: a prospective longitudinal study. Arthritis Rheum 2009; 61: 680-687.
41. Fattal I, Shental N, Mevorach D, Anaya JM, Livneh A, Langevitz P, Zandman-Goddard G, Pauzner R, Lerner M, Blank M, Hincapie ME, Gafter U, Naparstek Y, Shoenfeld Y, Domany E, Cohen IR: An antibody profile of systemic lupus erythematosus detected by antigen microarray. Immunology 2010; 130: 337-343.
42. Carbotte RM, Denburg SD, Denburg JA, Nahmias C, Garnett ES: Fluctuating cognitive abnormalities and cerebral glucose metabolism in neuropsychiatric systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 1992; 55: 1054-1059.
43. Denburg JA, Carbotte RM, Denburg SD: Neuronal antibodies and cognitive function in systemic lupus erythematosus. Neurology 1987; 37: 464-467.
44. Oda K, Matsushima E, Okubo Y, Ohta K, Murata Y, Koike R, Miyasaka N, Kato M: Abnormal regional cerebral blood flow in systemic lupus erythematosus patients with psychiatric symptoms. J Clin Psychiatry 2005; 66: 907-913.
45. Ikenouchi-Sugita A, Yoshimura R, Okamoto T, Umene-Nakano W, Ueda N, Hori H, Katsuki A, Saito K, Tanaka Y, Nakamura J: Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus. World J Biol Psychiatry 2010; 11: 121-128.
46. Ling MH, Perry PJ, Tsuang MT: Side effects of corticosteroid therapy. Psychiatric aspects. Arch Gen Psychiatry 1981; 38: 471-477.
47. Jones BD, Chouinard G: Clonazepam in the treatment of recurrent symptoms of depression and anxiety in a patient with systemic lupus erythematosus. Am J Psychiatry 1985; 142: 354-355.